Submitted by: Submitted by sankp
Views: 10
Words: 479
Pages: 2
Category: Business and Industry
Date Submitted: 05/03/2016 01:29 AM
Metastatic Hepatocellular Carcinoma (HCC) Market Size, Share, Trends and Growth, Analysis and Pipeline Review, H1 2016
Global Markets Direct's, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016', provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Metastatic Hepatocellular Carcinoma (HCC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Metastatic Hepatocellular Carcinoma (HCC) and features dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/metastatic-hepatocellular-carcinoma-hcc-pipeline-review-h1-2016
Scope
The report provides a snapshot of the global therapeutic landscape of Metastatic Hepatocellular Carcinoma (HCC)
The report reviews pipeline therapeutics for Metastatic Hepatocellular Carcinoma (HCC) by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
Table of Content
Table of Contents 2
List of Tables 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/169458
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Metastatic Hepatocellular Carcinoma (HCC) Overview 9
Therapeutics Development 10
Pipeline Products for Metastatic Hepatocellular Carcinoma (HCC) - Overview 10
Pipeline Products for Metastatic Hepatocellular Carcinoma...